How it works?

Demostrating the interference of tissue processing in the evaluation of tissue biomarkers: the case of PD-L1


DESCRIPTION

Lab Talks - The Podcast Series

Hosting top-class Lab Professionals engaged in disseminating Anatomic Pathology Scenarios, Best Practices and Ideas.

Dr. Catarina Eloy

Ascolta "20 - Demonstrating the interference of tissue processing in the evaluation of tissue biomarkers: the case of PD-L1 - Dr. Catarina Eloy" su Spreaker.

Back



RELATED ARTICLES

Mesenchymal Stem Cells and PRP Therapy...

Marine Benois...


Obesity Surgery
Hematoxylin

Mesenchymal stem cells (MSCs) are multipotent stem cells found in bone marrow that are important for making and repairing skeletal tissues, […]...



Reliability of programmed death ligand 1 (PD-L1) tumor proportion scor...

Costantino Ricci, Elisa Capizzi and others...


Therapeutic Advances in Medical Oncology
Microfix

Introduction: Programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assessment is mandatory for the single agent pembrolizumab treatment of patients...



Diapath Lab Talks | Privacy Policy